CNE000001K65
CNE000001K65
YIFAN PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.132.949.330 | 5.159.823.228 | 0.5% |
| Cost of Revenue | 2.726.658.412 | 2.713.055.053 | 0.5% |
| Gross Profit | 2.406.290.918 | 2.446.768.175 | 1.7% |
| 1.829.046.010 | 1.842.355.962 | 0.7% | |
| Operating Income | 577.244.908 | 604.412.213 | 4.5% |
| Pretax Income | 423.704.237 | 388.656.952 | 9.0% |
| Net Income Common Stockholders | 402.021.184 | 385.967.573 | 4.2% |
| -- | -- | -- | |
| -- | -- | -- |